Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder.[L6010,L52145]
Synonyms
Dextroamphetamine adipate
(+)-α-methylphenethylamine
Dexanfetamina
(S)-amphetamine
(+)-amphetamine
Dextroamphetamine
Dextroamphetamine saccharate
d-amphetamine
Dexamfetamine
Dexamphetamine
(+)-(S)-amphetamine
Dexamfetamina
Dextroamphetamine sulfate
(S)-α-methylbenzeneethanamine
(+)-α-methylphenylethylamine
Dexamfetaminum
(S)-(+)-amphetamine
(S)-(+)-β-phenylisopropylamine
(S)-1-phenyl-2-propylamine
Desamfetamina
(αS)-α-methylbenzeneethanamine
(S)-1-phenyl-2-aminopropane
Brand Names
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Suflate
ProCentra
Dextroamphetamine Sulfate
Teva-dextroamphetamine SR
Apo-dextroamphetamine SR
Mixed Salts of a Single Entity Amphetamine Product XR
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682